Copyright for articles published in this journal is retained by the journal.
Author Biographies
K Tengue
Departments of Urology, CHU Sylvanus Olympio, Lome, Togo
T Kpatcha
Departments of Urology, CHU Sylvanus Olympio, Lome, Togo
E Sewa
Departments of Urology, CHU Sylvanus Olympio, Lome, Togo
K Sikpa
Departments of Urology, CHU Sylvanus Olympio, Lome, Togo
G Botcho
Departments of Urology, CHU Sylvanus Olympio, Lome, Togo
E Leloua
Departments of Urology, CHU Sylvanus Olympio, Lome, Togo
A Amavi
Departments of Urology, CHU Sylvanus Olympio, Lome, Togo
A Mouhari-Toure
Dermatology Departement, CHU, Kara, Togo
K Amegbor
Departments of Anatomopathology, CHU Sylvanus Olympio, Lome, Togo
E Dosseh
Department of General Surgery, CHU Sylvanus Olympio, Lome, Togo
Main Article Content
Prostate cancer revealed by skin metastasis: A case report in black African man
K Tengue
T Kpatcha
E Sewa
K Sikpa
G Botcho
E Leloua
A Amavi
A Mouhari-Toure
K Amegbor
E Dosseh
Abstract
Introduction: Prostate cancer is the most common male malignancy in Togo. Most patients present with advanced and metastatic disease. Skin metastasis from prostate cancer is very rare and it occurs late and often with a poor prognosis. We report a case in a 52-year-old Togolese man where the skin lesions reveal the disease and with a good prognosis three years after treatment. Observation: In 2012, a 52-year-old man presented in dermatology with multiple painless skin nodules on his chest. He did not have lower urinary tract symptoms The biopsy of the skin lesion (three nodules) showed a metastasis of adenocarcinoma type tumor and tumor markers performed pointed toward prostate as primary site. In urology a diagnostic biopsy (12 cores) of prostate revealed a high-grade (Gleason grade 4 + 4) adenocarcinoma. We performed a bilateral orchiectomy as androgen deprivation therapy and one month after this treatment the skin lesions have disappeared. Conclusion: Skin metastasis of prostate cancer is rare and their recognition remains poor among practitioners requiring biopsy of the lesions. The prognosis could be better in newly diagnosed prostate cancer.
African Journal of Urology (2017) 23, 204–207
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.